Sybleu Inc. (OTCPK: SYBE)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
Sybleu Inc. (OTCPK: SYBE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $583.74K and employs 2 people.
trading between 0.01 and 0.15.
Tweenvest scores Sybleu Inc. across four factors: quality 6/100. Its strongest factor is quality.
SYBE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $583.74K
- Revenue (TTM)
- $11.70K
- P/E
- —
- EPS
- -0.03
- Dividend yield
- —
- Beta (5Y)
- 1.68
- 52-week high
- $0.15
- 52-week low
- $0.01
- Avg volume (3M)
- —
- Shares outstanding
- 10.61M
- Employees
- 2
- Next earnings
- —
About Sybleu Inc.
Established in 2020, SYBLEU Inc. specializes in developing regenerative medical applications. The firm's headquarters are located in Bronx, New York.
- ISIN
- US87114K1051
- Founded
- 2020
- Listed since
- May 30, 2023
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.